Pyxis Oncology (PYXS) Retained Earnings (2020 - 2025)

Pyxis Oncology (PYXS) has 6 years of Retained Earnings data on file, last reported at $53000.0 in Q4 2025.

• On a quarterly basis, Retained Earnings fell 99.99% year-over-year to $53000.0 in Q4 2025; TTM through Dec 2025 was $53000.0, a 99.99% decrease from a year earlier, with the FY2025 full-year figure at $53000.0, down 99.99% from the prior year.
• Retained Earnings for Q4 2025 stood at $53000.0, up from -$425.1 million in the prior quarter.
• Over the last five years, Retained Earnings for PYXS reached as high as $484.1 million in Q4 2024 and fell as low as -$425.1 million in Q3 2025.
• Historically, Retained Earnings has averaged $83.6 million across 5 years, with a median of $176.5 million in 2021.
• Across the five-year window, Retained Earnings surged 363816.49% in 2021 and plunged 188.33% in 2025, its largest moves.
• Year by year, Retained Earnings stood at $353.0 million in 2021, then climbed by 5.73% to $373.2 million in 2022, then increased by 10.34% to $411.8 million in 2023, then climbed by 17.55% to $484.1 million in 2024, then plunged by 99.99% to $53000.0 in 2025.
• Per Business Quant data, the three most recent Retained Earnings figures were $53000.0 in Q4 2025, -$425.1 million in Q3 2025, and -$403.1 million in Q2 2025.